http://pr.gaeatimes.com Mon, 17 Jan 2011 05:00:00 +0000 http://wordpress.org/?v=2.7.1 en hourly 1 http://pr.gaeatimes.com/merck-serono-and-domain-therapeutics-announce-an-agreement-to-develop-drugs-for-parkinsons-disease-40089/ http://pr.gaeatimes.com/merck-serono-and-domain-therapeutics-announce-an-agreement-to-develop-drugs-for-parkinsons-disease-40089/#comments Mon, 17 Jan 2011 05:00:00 +0000 Merck Serono http://pr.gaeatimes.com/merck-serono-and-domain-therapeutics-announce-an-agreement-to-develop-drugs-for-parkinsons-disease-40089/ Read this article on Gaea Times at : Merck Serono and Domain Therapeutics Announce an Agreement to Develop Drugs for Parkinson's Disease.]]> http://pr.gaeatimes.com/merck-serono-and-domain-therapeutics-announce-an-agreement-to-develop-drugs-for-parkinsons-disease-40089/feed/ http://pr.gaeatimes.com/brighter-futures-in-ms-inspiring-short-film-premieres-in-brussels-39948/ http://pr.gaeatimes.com/brighter-futures-in-ms-inspiring-short-film-premieres-in-brussels-39948/#comments Wed, 12 Jan 2011 05:00:00 +0000 Merck Serono http://pr.gaeatimes.com/brighter-futures-in-ms-inspiring-short-film-premieres-in-brussels-39948/ Original article on Gaea Times at  : Brighter Futures in MS - Inspiring Short Film Premieres in Brussels.]]> http://pr.gaeatimes.com/brighter-futures-in-ms-inspiring-short-film-premieres-in-brussels-39948/feed/ http://pr.gaeatimes.com/merck-serono-and-san-raffaele-scientific-institute-to-collaborate-on-research-in-neurodegenerative-diseases-39136/ http://pr.gaeatimes.com/merck-serono-and-san-raffaele-scientific-institute-to-collaborate-on-research-in-neurodegenerative-diseases-39136/#comments Mon, 13 Dec 2010 05:00:00 +0000 Merck Serono http://pr.gaeatimes.com/merck-serono-and-san-raffaele-scientific-institute-to-collaborate-on-research-in-neurodegenerative-diseases-39136/ >>>.]]> http://pr.gaeatimes.com/merck-serono-and-san-raffaele-scientific-institute-to-collaborate-on-research-in-neurodegenerative-diseases-39136/feed/ http://pr.gaeatimes.com/merck-serono-announces-extension-of-fda-priority-review-period-for-cladribine-tablets-for-the-treatment-of-relapsing-forms-of-multiple-sclerosis-38479/ http://pr.gaeatimes.com/merck-serono-announces-extension-of-fda-priority-review-period-for-cladribine-tablets-for-the-treatment-of-relapsing-forms-of-multiple-sclerosis-38479/#comments Fri, 26 Nov 2010 05:00:00 +0000 Merck Serono http://pr.gaeatimes.com/merck-serono-announces-extension-of-fda-priority-review-period-for-cladribine-tablets-for-the-treatment-of-relapsing-forms-of-multiple-sclerosis-38479/ Merck Serono Announces Extension of FDA Priority Review Period for Cladribine Tablets for the Treatment of Relapsing Forms of Multiple Sclerosis.]]> http://pr.gaeatimes.com/merck-serono-announces-extension-of-fda-priority-review-period-for-cladribine-tablets-for-the-treatment-of-relapsing-forms-of-multiple-sclerosis-38479/feed/ http://pr.gaeatimes.com/merck-serono-enrollment-completed-for-oracle-ms-study-of-cladribine-tablets-in-patients-at-risk-of-developing-ms-38087/ http://pr.gaeatimes.com/merck-serono-enrollment-completed-for-oracle-ms-study-of-cladribine-tablets-in-patients-at-risk-of-developing-ms-38087/#comments Wed, 17 Nov 2010 05:00:00 +0000 Merck Serono http://pr.gaeatimes.com/merck-serono-enrollment-completed-for-oracle-ms-study-of-cladribine-tablets-in-patients-at-risk-of-developing-ms-38087/ Merck Serono: Enrollment Completed for ORACLE MS Study of Cladribine Tablets in Patients at Risk of Developing MS.]]> http://pr.gaeatimes.com/merck-serono-enrollment-completed-for-oracle-ms-study-of-cladribine-tablets-in-patients-at-risk-of-developing-ms-38087/feed/ http://pr.gaeatimes.com/merck-serono-ready-to-use-formulation-of-recombinant-growth-hormone-saizen-recommended-for-approval-in-europe-37931/ http://pr.gaeatimes.com/merck-serono-ready-to-use-formulation-of-recombinant-growth-hormone-saizen-recommended-for-approval-in-europe-37931/#comments Mon, 15 Nov 2010 05:00:00 +0000 Merck Serono http://pr.gaeatimes.com/merck-serono-ready-to-use-formulation-of-recombinant-growth-hormone-saizen-recommended-for-approval-in-europe-37931/ Original source  : Merck Serono: Ready-to-Use Formulation of Recombinant Growth Hormone Saizen Recommended for Approval in Europe.]]> http://pr.gaeatimes.com/merck-serono-ready-to-use-formulation-of-recombinant-growth-hormone-saizen-recommended-for-approval-in-europe-37931/feed/ http://pr.gaeatimes.com/merck-serono-announces-top-line-results-of-long-term-study-of-safinamide-as-add-on-treatment-to-levodopa-in-advanced-parkinsons-disease-37503/ http://pr.gaeatimes.com/merck-serono-announces-top-line-results-of-long-term-study-of-safinamide-as-add-on-treatment-to-levodopa-in-advanced-parkinsons-disease-37503/#comments Thu, 04 Nov 2010 05:00:00 +0000 Merck Serono http://pr.gaeatimes.com/merck-serono-announces-top-line-results-of-long-term-study-of-safinamide-as-add-on-treatment-to-levodopa-in-advanced-parkinsons-disease-37503/ Read the original article  : Merck Serono Announces Top-Line Results of Long-Term Study of Safinamide as Add-on Treatment to Levodopa in Advanced Parkinson's Disease.]]> http://pr.gaeatimes.com/merck-serono-announces-top-line-results-of-long-term-study-of-safinamide-as-add-on-treatment-to-levodopa-in-advanced-parkinsons-disease-37503/feed/ http://pr.gaeatimes.com/merck-serono-sells-theramex-to-teva-for-eur-265-million-37232/ http://pr.gaeatimes.com/merck-serono-sells-theramex-to-teva-for-eur-265-million-37232/#comments Thu, 28 Oct 2010 05:00:00 +0000 Merck Serono http://pr.gaeatimes.com/merck-serono-sells-theramex-to-teva-for-eur-265-million-37232/ Read the original article  : Merck Serono Sells Théramex to Teva for EUR 265 Million.]]> http://pr.gaeatimes.com/merck-serono-sells-theramex-to-teva-for-eur-265-million-37232/feed/ http://pr.gaeatimes.com/merck-serono-reflex-study-results-show-treatment-with-rebifr-delays-conversion-to-ms-in-patients-with-first-clinical-signs-of-the-disease-37034/ http://pr.gaeatimes.com/merck-serono-reflex-study-results-show-treatment-with-rebifr-delays-conversion-to-ms-in-patients-with-first-clinical-signs-of-the-disease-37034/#comments Mon, 25 Oct 2010 05:00:00 +0000 Merck Serono http://pr.gaeatimes.com/merck-serono-reflex-study-results-show-treatment-with-rebifr-delays-conversion-to-ms-in-patients-with-first-clinical-signs-of-the-disease-37034/ Merck Serono: REFLEX Study Results Show Treatment With Rebif(R) Delays Conversion to MS in Patients With First Clinical Signs of the Disease.]]> http://pr.gaeatimes.com/merck-serono-reflex-study-results-show-treatment-with-rebifr-delays-conversion-to-ms-in-patients-with-first-clinical-signs-of-the-disease-37034/feed/ http://pr.gaeatimes.com/merck-serono-to-introduce-rebidosetm-the-rebifr-single-use-pre-filled-pen-for-treatment-of-multiple-sclerosis-36674/ http://pr.gaeatimes.com/merck-serono-to-introduce-rebidosetm-the-rebifr-single-use-pre-filled-pen-for-treatment-of-multiple-sclerosis-36674/#comments Fri, 15 Oct 2010 05:00:00 +0000 Merck Serono http://blog.taragana.com/pr/merck-serono-to-introduce-rebidosetm-the-rebifr-single-use-pre-filled-pen-for-treatment-of-multiple-sclerosis-36674/ Original source on Gaea Times at : Merck Serono to Introduce RebiDose(TM), the Rebif(R) Single Use Pre-filled Pen for Treatment of Multiple Sclerosis.]]> http://pr.gaeatimes.com/merck-serono-to-introduce-rebidosetm-the-rebifr-single-use-pre-filled-pen-for-treatment-of-multiple-sclerosis-36674/feed/ http://pr.gaeatimes.com/merck-serono-new-presentation-of-cyanokitr-approved-in-europe-36532/ http://pr.gaeatimes.com/merck-serono-new-presentation-of-cyanokitr-approved-in-europe-36532/#comments Wed, 13 Oct 2010 05:00:00 +0000 Merck Serono http://blog.taragana.com/pr/merck-serono-new-presentation-of-cyanokitr-approved-in-europe-36532/ Merck Serono: New Presentation of Cyanokit(R) Approved in Europe.]]> http://pr.gaeatimes.com/merck-serono-new-presentation-of-cyanokitr-approved-in-europe-36532/feed/ http://pr.gaeatimes.com/ablynx-and-merck-serono-enter-into-second-agreement-to-co-discover-and-co-develop-nanobodies-r-36315/ http://pr.gaeatimes.com/ablynx-and-merck-serono-enter-into-second-agreement-to-co-discover-and-co-develop-nanobodies-r-36315/#comments Mon, 11 Oct 2010 05:00:00 +0000 Merck Serono http://blog.taragana.com/pr/ablynx-and-merck-serono-enter-into-second-agreement-to-co-discover-and-co-develop-nanobodies-r-36315/ Read more : Ablynx and Merck Serono Enter into Second Agreement To Co-Discover and Co-Develop Nanobodies (R).]]> http://pr.gaeatimes.com/ablynx-and-merck-serono-enter-into-second-agreement-to-co-discover-and-co-develop-nanobodies-r-36315/feed/ http://pr.gaeatimes.com/merck-serono-notified-ema-of-its-intention-to-appeal-chmp-opinion-on-cladribine-tablets-in-ms-36322/ http://pr.gaeatimes.com/merck-serono-notified-ema-of-its-intention-to-appeal-chmp-opinion-on-cladribine-tablets-in-ms-36322/#comments Mon, 11 Oct 2010 05:00:00 +0000 Merck Serono http://blog.taragana.com/pr/merck-serono-notified-ema-of-its-intention-to-appeal-chmp-opinion-on-cladribine-tablets-in-ms-36322/ Merck Serono Notified EMA of its Intention to Appeal CHMP Opinion on Cladribine Tablets in MS.]]> http://pr.gaeatimes.com/merck-serono-notified-ema-of-its-intention-to-appeal-chmp-opinion-on-cladribine-tablets-in-ms-36322/feed/ http://pr.gaeatimes.com/merck-serono-fda-grants-priority-review-to-cladribine-tablets-for-the-treatment-of-relapsing-forms-of-ms-24958/ http://pr.gaeatimes.com/merck-serono-fda-grants-priority-review-to-cladribine-tablets-for-the-treatment-of-relapsing-forms-of-ms-24958/#comments Wed, 28 Jul 2010 05:00:00 +0000 Merck Serono http://blog.taragana.com/pr/merck-serono-fda-grants-priority-review-to-cladribine-tablets-for-the-treatment-of-relapsing-forms-of-ms-24958/ Read this article on Gaea Times at : Merck Serono: FDA Grants Priority Review to Cladribine Tablets for the Treatment of Relapsing Forms of MS.]]> http://pr.gaeatimes.com/merck-serono-fda-grants-priority-review-to-cladribine-tablets-for-the-treatment-of-relapsing-forms-of-ms-24958/feed/ http://pr.gaeatimes.com/merck-seronos-cladribine-tablets-for-ms-approved-in-russia-23911/ http://pr.gaeatimes.com/merck-seronos-cladribine-tablets-for-ms-approved-in-russia-23911/#comments Mon, 12 Jul 2010 05:00:00 +0000 Merck Serono http://blog.taragana.com/pr/merck-seronos-cladribine-tablets-for-ms-approved-in-russia-23911/ Source  : Merck Serono's Cladribine Tablets for MS Approved in Russia.]]> http://pr.gaeatimes.com/merck-seronos-cladribine-tablets-for-ms-approved-in-russia-23911/feed/ http://pr.gaeatimes.com/merck-serono-to-award-grant-to-innovative-research-projects-in-fertility-23131/ http://pr.gaeatimes.com/merck-serono-to-award-grant-to-innovative-research-projects-in-fertility-23131/#comments Tue, 29 Jun 2010 05:00:00 +0000 Merck Serono http://blog.taragana.com/pr/merck-serono-to-award-grant-to-innovative-research-projects-in-fertility-23131/ Source article on Gaea Times at  : Merck Serono to Award Grant to Innovative Research Projects in Fertility.]]> http://pr.gaeatimes.com/merck-serono-to-award-grant-to-innovative-research-projects-in-fertility-23131/feed/ http://pr.gaeatimes.com/merck-serono-calls-for-entries-to-real-ms-your-story-a-global-competition-to-raise-awareness-of-multiple-sclerosis-22921/ http://pr.gaeatimes.com/merck-serono-calls-for-entries-to-real-ms-your-story-a-global-competition-to-raise-awareness-of-multiple-sclerosis-22921/#comments Fri, 25 Jun 2010 05:00:00 +0000 Merck Serono S A http://blog.taragana.com/pr/merck-serono-calls-for-entries-to-real-ms-your-story-a-global-competition-to-raise-awareness-of-multiple-sclerosis-22921/ Read the original article: here.]]> http://pr.gaeatimes.com/merck-serono-calls-for-entries-to-real-ms-your-story-a-global-competition-to-raise-awareness-of-multiple-sclerosis-22921/feed/ http://pr.gaeatimes.com/merck-serono-data-on-safinamide-to-be-presented-at-the-14th-mds-meeting-21800/ http://pr.gaeatimes.com/merck-serono-data-on-safinamide-to-be-presented-at-the-14th-mds-meeting-21800/#comments Thu, 10 Jun 2010 05:00:00 +0000 Merck Serono http://blog.taragana.com/pr/merck-serono-data-on-safinamide-to-be-presented-at-the-14th-mds-meeting-21800/ Source  : Merck Serono: Data on Safinamide to Be Presented at the 14th MDS Meeting.]]> http://pr.gaeatimes.com/merck-serono-data-on-safinamide-to-be-presented-at-the-14th-mds-meeting-21800/feed/ http://pr.gaeatimes.com/merck-serono-resubmits-us-application-for-cladribine-tablets-as-a-potential-ms-therapy-21591/ http://pr.gaeatimes.com/merck-serono-resubmits-us-application-for-cladribine-tablets-as-a-potential-ms-therapy-21591/#comments Tue, 08 Jun 2010 05:00:00 +0000 Merck Serono http://blog.taragana.com/pr/merck-serono-resubmits-us-application-for-cladribine-tablets-as-a-potential-ms-therapy-21591/ Gaea News Network.]]> http://pr.gaeatimes.com/merck-serono-resubmits-us-application-for-cladribine-tablets-as-a-potential-ms-therapy-21591/feed/ http://pr.gaeatimes.com/your-story-your-voice-your-achievements-your-ideas-this-is-about-life-real-life-real-ms-20429/ http://pr.gaeatimes.com/your-story-your-voice-your-achievements-your-ideas-this-is-about-life-real-life-real-ms-20429/#comments Wed, 26 May 2010 05:00:00 +0000 Merck Serono http://blog.taragana.com/pr/your-story-your-voice-your-achievements-your-ideas-this-is-about-life-real-life-real-ms-20429/ Your Story, Your Voice, Your Achievements, Your Ideas … This Is About Life, Real Life, Real MS.]]> http://pr.gaeatimes.com/your-story-your-voice-your-achievements-your-ideas-this-is-about-life-real-life-real-ms-20429/feed/ http://pr.gaeatimes.com/international-thyroid-awareness-week-2010-to-focus-on-thyroid-disorders-and-pregnancy-20182/ http://pr.gaeatimes.com/international-thyroid-awareness-week-2010-to-focus-on-thyroid-disorders-and-pregnancy-20182/#comments Tue, 25 May 2010 05:00:00 +0000 Merck Serono http://blog.taragana.com/pr/international-thyroid-awareness-week-2010-to-focus-on-thyroid-disorders-and-pregnancy-20182/ Source  : International Thyroid Awareness Week 2010 to Focus on Thyroid Disorders and Pregnancy.]]> http://pr.gaeatimes.com/international-thyroid-awareness-week-2010-to-focus-on-thyroid-disorders-and-pregnancy-20182/feed/ http://pr.gaeatimes.com/data-from-merck-seronos-multiple-sclerosis-portfolio-to-be-presented-at-the-62nd-annual-meeting-of-the-american-academy-of-neurology-15407/ http://pr.gaeatimes.com/data-from-merck-seronos-multiple-sclerosis-portfolio-to-be-presented-at-the-62nd-annual-meeting-of-the-american-academy-of-neurology-15407/#comments Wed, 31 Mar 2010 05:00:00 +0000 Merck Serono http://blog.taragana.com/pr/data-from-merck-seronos-multiple-sclerosis-portfolio-to-be-presented-at-the-62nd-annual-meeting-of-the-american-academy-of-neurology-15407/ Data from Merck Serono's Multiple Sclerosis Portfolio to be Presented at the 62nd Annual Meeting of the American Academy of Neurology.]]> http://pr.gaeatimes.com/data-from-merck-seronos-multiple-sclerosis-portfolio-to-be-presented-at-the-62nd-annual-meeting-of-the-american-academy-of-neurology-15407/feed/ http://pr.gaeatimes.com/cardiff-university-and-merck-serono-launch-international-survey-for-couples-trying-to-conceive-14100/ http://pr.gaeatimes.com/cardiff-university-and-merck-serono-launch-international-survey-for-couples-trying-to-conceive-14100/#comments Thu, 04 Mar 2010 05:00:00 +0000 Merck Serono http://blog.taragana.com/pr/cardiff-university-and-merck-serono-launch-international-survey-for-couples-trying-to-conceive-14100/ Read the original article on Gaea Times at : Cardiff University and Merck Serono Launch International Survey for Couples Trying To Conceive.]]> http://pr.gaeatimes.com/cardiff-university-and-merck-serono-launch-international-survey-for-couples-trying-to-conceive-14100/feed/ http://pr.gaeatimes.com/two-year-results-from-clarity-study-with-cladribine-tablets-in-multiple-sclerosis-published-in-the-new-england-journal-of-medicine-11984/ http://pr.gaeatimes.com/two-year-results-from-clarity-study-with-cladribine-tablets-in-multiple-sclerosis-published-in-the-new-england-journal-of-medicine-11984/#comments Thu, 21 Jan 2010 05:00:00 +0000 Merck Serono http://blog.taragana.com/pr/two-year-results-from-clarity-study-with-cladribine-tablets-in-multiple-sclerosis-published-in-the-new-england-journal-of-medicine-11984/ Read the original article on Gaea Times at : Two-Year Results From CLARITY Study With Cladribine Tablets in Multiple Sclerosis Published in The New England Journal of Medicine.]]> http://pr.gaeatimes.com/two-year-results-from-clarity-study-with-cladribine-tablets-in-multiple-sclerosis-published-in-the-new-england-journal-of-medicine-11984/feed/ http://pr.gaeatimes.com/merck-serono-announces-collaboration-in-basic-and-clinical-research-in-multiple-sclerosis-10772/ http://pr.gaeatimes.com/merck-serono-announces-collaboration-in-basic-and-clinical-research-in-multiple-sclerosis-10772/#comments Wed, 16 Dec 2009 05:00:00 +0000 Merck Serono http://blog.taragana.com/pr/merck-serono-announces-collaboration-in-basic-and-clinical-research-in-multiple-sclerosis-10772/ Read more >>.]]> http://pr.gaeatimes.com/merck-serono-announces-collaboration-in-basic-and-clinical-research-in-multiple-sclerosis-10772/feed/ http://pr.gaeatimes.com/merck-serono-initiates-kamper-the-first-pan-european-registry-for-patients-under-kuvanr-therapy-10446/ http://pr.gaeatimes.com/merck-serono-initiates-kamper-the-first-pan-european-registry-for-patients-under-kuvanr-therapy-10446/#comments Thu, 10 Dec 2009 05:00:00 +0000 Merck Serono http://blog.taragana.com/pr/merck-serono-initiates-kamper-the-first-pan-european-registry-for-patients-under-kuvanr-therapy-10446/ Merck Serono Initiates KAMPER, the First Pan-European Registry for Patients Under Kuvan(R) Therapy.]]> http://pr.gaeatimes.com/merck-serono-initiates-kamper-the-first-pan-european-registry-for-patients-under-kuvanr-therapy-10446/feed/ http://pr.gaeatimes.com/merck-serono-to-expand-research-and-development-presence-in-china-9355/ http://pr.gaeatimes.com/merck-serono-to-expand-research-and-development-presence-in-china-9355/#comments Mon, 23 Nov 2009 05:00:00 +0000 Merck Serono http://blog.taragana.com/pr/merck-serono-to-expand-research-and-development-presence-in-china-9355/ Read : Merck Serono to Expand Research and Development Presence in China.]]> http://pr.gaeatimes.com/merck-serono-to-expand-research-and-development-presence-in-china-9355/feed/ http://pr.gaeatimes.com/merck-serono-named-as-a-top-employer-by-science-magazine-6918/ http://pr.gaeatimes.com/merck-serono-named-as-a-top-employer-by-science-magazine-6918/#comments Mon, 05 Oct 2009 05:00:00 +0000 Prne http://blog.taragana.com/pr/merck-serono-named-as-a-top-employer-by-science-magazine-6918/ Read the original article: here.]]> http://pr.gaeatimes.com/merck-serono-named-as-a-top-employer-by-science-magazine-6918/feed/ http://pr.gaeatimes.com/merck-serono-submits-application-for-cladribine-tablets-as-a-potential-oral-short-course-multiple-sclerosis-therapy-in-the-united-states-6764/ http://pr.gaeatimes.com/merck-serono-submits-application-for-cladribine-tablets-as-a-potential-oral-short-course-multiple-sclerosis-therapy-in-the-united-states-6764/#comments Wed, 30 Sep 2009 05:00:00 +0000 Prne http://blog.taragana.com/pr/merck-serono-submits-application-for-cladribine-tablets-as-a-potential-oral-short-course-multiple-sclerosis-therapy-in-the-united-states-6764/ here.]]> http://pr.gaeatimes.com/merck-serono-submits-application-for-cladribine-tablets-as-a-potential-oral-short-course-multiple-sclerosis-therapy-in-the-united-states-6764/feed/ http://pr.gaeatimes.com/new-data-from-clarity-study-on-disease-activity-in-ms-patients-who-received-cladribine-tablets-presented-at-25th-ectrims-congress-5845/ http://pr.gaeatimes.com/new-data-from-clarity-study-on-disease-activity-in-ms-patients-who-received-cladribine-tablets-presented-at-25th-ectrims-congress-5845/#comments Fri, 11 Sep 2009 05:00:00 +0000 Prne http://blog.taragana.com/pr/new-data-from-clarity-study-on-disease-activity-in-ms-patients-who-received-cladribine-tablets-presented-at-25th-ectrims-congress-5845/ Gaea News Network.]]> http://pr.gaeatimes.com/new-data-from-clarity-study-on-disease-activity-in-ms-patients-who-received-cladribine-tablets-presented-at-25th-ectrims-congress-5845/feed/